The recent surge in investments into niche pharmaceutical companies, particularly those focusing on experimental therapies and difficult drug development programs, has fueled what some are calling "High Roller Pharma." https://lilianoukv345677.tblogz.com/high-roller-pharma-the-risky-wager-53307977